Clinical Trials Browser

Phase 2 × Unknown × EGFR Positive Non-small Cell Lung Cancer × Clear all

NCT03126799 2022-04-06

AvaTa

Phase 2 Unknown

EGFR Positive Non-small Cell Lung Cancer

NCT03382795 2021-07-15

Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients

Phase 2 Unknown

EGFR Positive Non-small Cell Lung Cancer